Cho Seong, Lee Yu-Ji, Kim Sung-Rok
Department of Internal Medicine, Division of Nephrology, Samsung Changwon Hospital, The Sungkyunkwan University School of Medicine, Changwon, Korea
Department of Internal Medicine, Division of Nephrology, Samsung Changwon Hospital, The Sungkyunkwan University School of Medicine, Changwon, Korea.
Perit Dial Int. 2017 Sep-Oct;37(5):529-534. doi: 10.3747/pdi.2016.00264. Epub 2017 Mar 27.
The purpose of this study was to evaluate the efficacy, complications, and mortality rate associated with acute peritoneal dialysis (PD) in patients with acute kidney injury (AKI).
A total of 75 patients who were treated at Samsung Changwon Hospital between February 2005 and March 2016 were included in the study sample. The outcomes included in-hospital survival, renal recovery, metabolic and fluid control rates, and technical success rates.
Refractory heart failure was the most frequent cause of acute PD (49.3%), followed by hepatic failure (20.0%), septic shock (14.7%), acute pancreatitis (9.3%), and unknown causes (6.7%). The hospital survival of patients in the acute PD was 48.0%. Etiologies of acute kidney injury (AKI) (refractory heart failure, acute pancreatitis compared with hepatic failure, septic shock or miscellaneous causes), use of inotropes, use of a ventilator, and simplified acute physiology score (SAPS) II were associated with survival differences. Maintenance dialysis required after survival was high (80.1% [29/36]) due to AKI etiologies (heart or hepatic failures). Metabolic and fluid control rates were 77.3%. The technical success rate for acute PD was 93.3%.
Acute PD remains a suitable treatment modality for patients with AKI in the era of continuous renal replacement therapy (CRRT). Nearly all patients who require dialysis can be dialyzed with acute PD without mechanical difficulties. This is particularly true in patients with refractory heart failure and acute pancreatitis who had a weak requirement for inotropes.
本研究旨在评估急性肾损伤(AKI)患者进行急性腹膜透析(PD)的疗效、并发症及死亡率。
研究样本纳入了2005年2月至2016年3月在三星昌原医院接受治疗的75例患者。观察指标包括院内生存率、肾功能恢复情况、代谢及液体控制率以及技术成功率。
难治性心力衰竭是急性腹膜透析最常见的病因(49.3%),其次是肝衰竭(20.0%)、感染性休克(14.7%)、急性胰腺炎(9.3%)及病因不明(6.7%)。急性腹膜透析患者的院内生存率为48.0%。急性肾损伤的病因(难治性心力衰竭、急性胰腺炎与肝衰竭、感染性休克或其他病因相比)、血管活性药物的使用、呼吸机的使用以及简化急性生理学评分(SAPS)II与生存差异相关。由于急性肾损伤病因(心脏或肝衰竭),存活后需要维持性透析的比例较高(80.1%[29/36])。代谢及液体控制率为77.3%。急性腹膜透析的技术成功率为93.3%。
在连续性肾脏替代治疗(CRRT)时代,急性腹膜透析仍是急性肾损伤患者的合适治疗方式。几乎所有需要透析的患者都可以进行急性腹膜透析,且无机械困难。对于难治性心力衰竭和急性胰腺炎且对血管活性药物需求较低的患者尤其如此。